Andrew Guggenhime | executive |
Grant Pickering | executive |
James Wassil | executive |
Jason Gerberry | analyst |
Jiale Song | analyst |
David Risinger | analyst |
Umer Raffat | analyst |
Seamus Fernandez | analyst |
Louise Chen | analyst |
Joseph Stringer | analyst |
Good afternoon, everyone. My name is Bo and I will be your conference operator today. At this time, time, I would like to welcome everyone to the Vaxcyte Fourth Quarter and Full Year 2023 Financial Results Conference Call. [Operator Instructions].Now at this time, I'll turn things over to Mr. Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte.